Verdezyne Raises $9M

Carlsbad, CA-based Verdezyne, an industrial biotechnology company developing methods for using yeast to make industrial chemicals, has raised $9 million in an ongoing $15.2 million venture round, according to spokeswoman Risa Goldman Burgess. She said today the funding is being used to validate technology, which Verdezyne recently disclosed, for making adipic acid, a key feedstock chemical used to make nylon. Verdezyne’s existing investors include Monitor Ventures, OVP Venture Partners, the Tech Coast Angels, and the Life Sciences Angels.

Bruce V. Bigelow was the editor of Xconomy San Diego from 2008 to 2018. Read more about his life and work here. Follow @bvbigelow

Trending on Xconomy